MUSE Microscopy Showcasing SmartPath MUSE Technology and Appointment of Yanbin (Eric) Qiang as President of Asia Markets
21 janv. 2025 19h20 HE
|
MUSE Microscopy, Inc.
IRVINE, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc. (the “Company”, “we”, “our”) is thrilled to announce the introduction of SmartPath MUSE Technology™ (SmartPath), the...
Proscia’s Growth More Than Doubles As Customers Adopt Enterprise Pathology
13 janv. 2025 08h00 HE
|
Proscia
Record year comes as the rise of precision medicine drives a surge in demand
Enterprise Imaging Growth Opportunities Report to 2028 - Oncology and Digital Pathology Enterprise Imaging Solutions Present Growth Opportunities
09 déc. 2024 09h26 HE
|
Research and Markets
Dublin, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The "Growth Opportunities in Enterprise Imaging, Global, 2023-2028" report has been added to ResearchAndMarkets.com's offering.Medical imaging is no longer...
CB Insights Recognizes Proscia Among Most Promising Digital Health Companies Of 2024
05 déc. 2024 07h45 HE
|
Proscia
Proscia also ranks as the top vendor in diagnostic digital pathology market landscapes.
MUSE Microscopy, Inc. is Entering a New Era of Digital Pathology with the Development of the SmartPath MUSE Technology (SmartPath) Imager
26 nov. 2024 17h46 HE
|
MUSE Microscopy, Inc.
MUSE Microscopy, Inc. is entering a new era of digital pathology with the development of the SmartPath MUSE Technology (SmartPath) Imager.
Pivotal Developmental Milestone Unveiled by MUSE Microscopy, Inc. at CAP24 Pathology Conference
13 nov. 2024 17h36 HE
|
MUSE Microscopy, Inc.
MUSE Microscopy, Inc., has reached a pivotal developmental milestone, unveiling a preliminary version of its innovative SmartPath Imager.
KLAS Research Recognizes Proscia For Improving Patient Outcomes
22 oct. 2024 08h00 HE
|
Proscia
Proscia's Concentriq software platform was named a KLAS 2024 Emerging Solutions Top 20 winner for improving patient outcomes.
Proscia Launches Concentriq Embeddings and Developer Toolkit to Unleash Pathology AI Development
02 oct. 2024 08h00 HE
|
Proscia
Life sciences organizations can rapidly build AI algorithms to discover biomarkers, optimize clinical trials, and advance companion diagnostics
Fimlab Is Adopting Proscia’s Software To Realize The Promise Of AI-Enabled Pathology
09 sept. 2024 02h00 HE
|
Proscia
Fimlab Laboratories will use Proscia’s software platform to help its pathologists generate more precise results with artificial intelligence (AI).
Life Sciences Organizations Gain New Real-World Data Offering To Bring Precision Therapies And Diagnostics To Patients
04 sept. 2024 08h00 HE
|
Proscia
Proscia customers can leverage over 10 million de-identified pathology images alongside corresponding clinical and genomic data